Streetbeat News

Price Targets

CRC

RBC Capital analyst Scott Hanold has reiterated an Outperform rating on California Resources (NYSE:CRC) and maintained a $65 price target.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:33 pm

GCMG

JP Morgan analyst Kenneth Worthington maintains a Neutral rating on GCM Grosvenor (NASDAQ:GCMG) and lowers the price target from $10.5 to $10.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:32 pm

AKBA

Akebia Therapeutics shares are trading higher after HC Wainwright & Co. maintained a Buy rating on the stock and raised its price target from $6 to $7.5.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:32 pm

CYH

RBC Capital analyst Ben Hendrix has reiterated an Outperform rating on Community Health Systems (NYSE:CYH) and maintained a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:32 pm

CIB

JP Morgan analyst Yuri Fernandes maintains an Underweight rating on BanColombia (NYSE:CIB) and lowers the price target from $36 to $35.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:30 pm

ARDT

RBC Capital has initiated coverage on Ardent Health Partners (NYSE:ARDT) with an Outperform rating and a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:30 pm

SO

JP Morgan analyst Jeremy Tonet maintains an Underweight rating on Southern (NYSE:SO) but raises the price target from $80 to $87.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:28 pm

STEP

JP Morgan analyst Kenneth Worthington maintains an Overweight rating on StepStone Group (NASDAQ:STEP) and raises the price target from $51 to $56.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:26 pm

PX

JP Morgan analyst Ken Worthington maintains a Neutral rating on P10 (NYSE:PX) and raises the price target from $9.5 to $11.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:25 pm

SKWD

Keefe, Bruyette & Woods analyst Meyer Shields maintains an Outperform rating on Skyward Specialty (NASDAQ:SKWD) and raises the price target from $46 to $47.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:24 pm